Search Results for agency_names:"Justice Department"

SpecGx LLC has applied to the Drug Enforcement Administration (DEA) to become an importer of certain controlled substances. The company intends to import specific drugs, including Tapentadol and Thebaine, for manufacturing purposes to create Active Pharmaceutical Ingredients. This notice allows registered manufacturers and other stakeholders to submit comments or request a hearing about this application by April 25, 2025. Approval for import will be strictly for manufacturing purposes and not for importing finished drug forms for sale.

The Department of Justice has announced a proposed Consent Decree in the case of United States v. Roger J. LaPant, Jr., related to violations of the Clean Water Act. The decree involves the defendant being required to pay a civil penalty and perform compensatory mitigation for discharging pollutants into U.S. waters without a permit. Public comments on this proposal can be submitted within thirty days of the notice. The document can be viewed online or at the Clerk's Office of the United States District Court for the Eastern District of California, although physical access may be limited due to COVID-19.

The Department of Justice's Antitrust Division has announced that the Expeditionary Missions Consortium—Crane (EMC2) filed notifications about updates to its membership. These updates were sent to the Attorney General and the Federal Trade Commission as part of a rule under the National Cooperative Research and Production Act of 1993. This act limits the recovery of damages by antitrust plaintiffs in certain situations. The consortium added many new members, including research institutions and companies from various states. Membership in the consortium remains open, and EMC2 plans to notify authorities of future changes in its membership.

The Department of Justice's Antitrust Division has announced changes in the membership of the Medical Technology Enterprise Consortium (MTEC) under the National Cooperative Research and Production Act of 1993. This notice, filed on January 6, 2025, allows for the extension of limitations on antitrust plaintiffs' recoveries against consortium members. The recent additions include a variety of organizations, from AccelerMED LLC in Minnesota to Zeteo Tech, Inc. in Maryland. The group remains open to new members, and MTEC will continue to update the membership as necessary.

The Department of Justice is inviting public comments on the proposed extension of an existing information collection by the FBI's Hazardous Devices School. This form, known as FD-731, is used to collect information on prospective students' identities and qualifications and to assess their security clearance status. The aim is to ensure these individuals have the necessary access to sensitive law enforcement facilities and information. The public comment period is open for 60 days, concluding on April 30, 2021, and the feedback will help evaluate and improve the collection process.

The Defense Electronics Consortium (DEC) has filed notifications with the Attorney General and the Federal Trade Commission regarding changes in its membership under the National Cooperative Research and Production Act of 1993. This filing aims to ensure that antitrust plaintiffs can only recover actual damages under certain conditions. DEC has stated that it is no longer accepting new members but will continue updating membership changes. Previous notifications have been noted in the Federal Register on different dates, highlighting the organization's compliance with regulatory requirements.

The Drug Enforcement Administration (DEA), part of the Department of Justice, has released a notice regarding an extension of a previously approved information collection related to the registration of those handling controlled substances. This involves DEA Forms 225, 225a, and 225b for businesses and individuals involved in the manufacturing, distribution, or research of controlled substances. The DEA is seeking public comments on the necessity, accuracy, and potential burden of this information collection process, which is estimated to affect 16,560 registrants and require 3,323 hours annually. Comments are welcome until May 27, 2025.

The Bytecode Alliance Foundation has informed the Attorney General and the Federal Trade Commission of changes in its membership as required by the National Cooperative Research and Production Act of 1993. Specifically, companies such as Red Hat Inc., Broadcom Inc., Liquid Reply GmbH, and Cisco Systems Inc. have exited the group. Despite these changes, the membership remains open, and the Foundation plans to update future membership changes. This filing intends to extend the Act's provisions that limit antitrust plaintiff's recovery to actual damages under certain conditions.

Mylan Pharmaceuticals, Inc. has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of basic classes of controlled substances. Interested parties, such as registered bulk manufacturers, can submit electronic comments or objections about this application by March 20, 2025, or request a hearing. Comments should be submitted through the Federal eRulemaking Portal, and requests for a hearing should be sent to the DEA's specified addresses. Mylan Pharmaceuticals seeks authorization to import controlled substances in finished dosage form for commercial distribution, with certain restrictions aligning with legal requirements.

The Petroleum Environmental Research Forum (PERF) submitted notifications about changes in its membership to the Attorney General and the Federal Trade Commission on December 17, 2024. This was done to extend the Act's provisions of limiting antitrust plaintiffs' recovery to actual damages under certain conditions. Specifically, Project Navigator, Ltd., has joined as a new member of PERF's research venture. The notice assures that membership in this research project remains open and that future changes will continue to be disclosed.